Is Sellas Life Stock a Good Investment?
Sellas Life Investment Advice | SLS |
- Examine Sellas Life's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Sellas Life's leadership team and their track record. Good management can help Sellas Life navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Sellas Life's business and its evolving consumer preferences.
- Compare Sellas Life's performance and market position to its competitors. Analyze how Sellas Life is positioned in terms of product offerings, innovation, and market share.
- Check if Sellas Life pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Sellas Life's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Sellas Life Sciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Sellas Life Sciences is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Sellas Life Stock
Researching Sellas Life's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company recorded a loss per share of 0.67. Sellas Life Sciences last dividend was issued on the 8th of November 2019. The entity had 1:50 split on the 8th of November 2019.
To determine if Sellas Life is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Sellas Life's research are outlined below:
| Sellas Life Sciences generated a negative expected return over the last 90 days | |
| Sellas Life Sciences may become a speculative penny stock | |
| Sellas Life Sciences has high historical volatility and very poor performance | |
| Reported Net Loss for the year was (37.34 M) with profit before taxes, overhead, and interest of 900 K. | |
| Sellas Life Sciences has about 26.99 M in cash with (31.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Sellas Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from forbes.com: NASA Yule Log Video Stars Four Blazing RS-25 Rocket Engines |
Sellas Life Quarterly Accounts Payable |
|
Sellas Life uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Sellas Life Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Sellas Life's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Sellas Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Sellas Life's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-07 | 2024-09-30 | -0.1267 | -0.1 | 0.0267 | 21 | ||
2024-08-13 | 2024-06-30 | -0.16 | -0.13 | 0.03 | 18 | ||
2023-08-10 | 2023-06-30 | -0.35 | -0.31 | 0.04 | 11 | ||
2024-05-14 | 2024-03-31 | -0.16 | -0.21 | -0.05 | 31 | ||
2022-11-14 | 2022-09-30 | -0.39 | -0.34 | 0.05 | 12 | ||
2022-08-11 | 2022-06-30 | -0.35 | -0.41 | -0.06 | 17 | ||
2021-11-12 | 2021-09-30 | -0.38 | -0.45 | -0.07 | 18 | ||
2020-05-14 | 2020-03-31 | -0.74 | -0.66 | 0.08 | 10 |
Know Sellas Life's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Sellas Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sellas Life Sciences backward and forwards among themselves. Sellas Life's institutional investor refers to the entity that pools money to purchase Sellas Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Virtu Financial Llc | 2024-06-30 | 63.8 K | Xtx Topco Ltd | 2024-09-30 | 62.8 K | Springbok Capital Management, Llc | 2024-09-30 | 58.3 K | Lpl Financial Corp | 2024-09-30 | 51.9 K | Citadel Advisors Llc | 2024-09-30 | 47.3 K | Mariner Wealth Advisors Llc | 2024-06-30 | 44.9 K | Jane Street Group Llc | 2024-06-30 | 28 K | Two Sigma Investments Llc | 2024-09-30 | 16.6 K | Charles Schwab Investment Management Inc | 2024-09-30 | 16.2 K | Vanguard Group Inc | 2024-09-30 | 2.3 M | Anson Funds Management Lp | 2024-09-30 | 793.8 K |
Sellas Life's market capitalization trends
The company currently falls under 'Micro-Cap' category with a total capitalization of 79.53 M.Market Cap |
|
Sellas Life's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (8.67) | (9.11) | |
| Return On Capital Employed | 5.04 | 5.29 | |
| Return On Assets | (6.00) | (6.30) | |
| Return On Equity | 4.68 | 4.92 |
Determining Sellas Life's profitability involves analyzing its financial statements and using various financial metrics to determine if Sellas Life is a good buy. For example, gross profit margin measures Sellas Life's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Sellas Life's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Sellas Life's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sellas Life Sciences. Check Sellas Life's Beneish M Score to see the likelihood of Sellas Life's management manipulating its earnings.
Evaluate Sellas Life's management efficiency
Sellas Life Sciences has Return on Asset of (1.2915) % which means that on every $100 spent on assets, it lost $1.2915. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (8.8806) %, meaning that it generated no profit with money invested by stockholders. Sellas Life's management efficiency ratios could be used to measure how well Sellas Life manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Sellas Life's Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 4.92 in 2024, whereas Return On Tangible Assets are likely to drop (9.11) in 2024. At this time, Sellas Life's Intangibles To Total Assets are comparatively stable compared to the past year. Asset Turnover is likely to gain to 0.07 in 2024, whereas Total Assets are likely to drop slightly above 5.9 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.29) | (0.27) | |
| Tangible Book Value Per Share | (0.36) | (0.34) | |
| Enterprise Value Over EBITDA | 52.59 | 55.22 | |
| Price Book Value Ratio | (3.69) | (3.51) | |
| Enterprise Value Multiple | 52.59 | 55.22 | |
| Price Fair Value | (3.69) | (3.51) | |
| Enterprise Value | 27.8 M | 26.4 M |
The decision-making processes within Sellas Life are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Beta 2.396 |
Basic technical analysis of Sellas Stock
As of the 30th of November, Sellas Life has the Variance of 9.61, coefficient of variation of (1,871), and Risk Adjusted Performance of (0.03). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sellas Life Sciences, as well as the relationship between them. Please validate Sellas Life Sciences information ratio and kurtosis to decide if Sellas Life is priced more or less accurately, providing market reflects its prevalent price of 1.13 per share. Given that Sellas Life Sciences is a hitting penny stock territory we recommend to closely look at its jensen alpha.Sellas Life's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sellas Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sellas Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sellas Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kalin Katherine Bach over three months ago Acquisition by Kalin Katherine Bach of 19000 shares of Sellas Life subject to Rule 16b-3 | ||
Cicic Dragan over three months ago Disposition of 35000 shares by Cicic Dragan of Sellas Life at 1.89 subject to Rule 16b-3 | ||
Cicic Dragan over three months ago Disposition of 65000 shares by Cicic Dragan of Sellas Life at 0.5195 subject to Rule 16b-3 | ||
Jane Wasman over six months ago Acquisition by Jane Wasman of 25000 shares of Sellas Life at 1.38 subject to Rule 16b-3 | ||
Angelos Stergiou over six months ago Acquisition or disposition of Sellas Life securities by Angelos Stergiou | ||
Angelos Stergiou over a year ago Acquisition by Angelos Stergiou of 70000 shares of Sellas Life subject to Rule 16b-3 | ||
Angelos Stergiou over a year ago Acquisition by Angelos Stergiou of 450135 shares of Sellas Life subject to Rule 16b-3 | ||
Angelos Stergiou over a year ago Acquisition by Angelos Stergiou of 58000 shares of Sellas Life subject to Rule 16b-3 |
Sellas Life's Outstanding Corporate Bonds
Sellas Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sellas Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sellas bonds can be classified according to their maturity, which is the date when Sellas Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Understand Sellas Life's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Sellas Life's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (2.13) | |||
| Mean Deviation | 2.25 | |||
| Coefficient Of Variation | (1,871) | |||
| Standard Deviation | 3.1 | |||
| Variance | 9.61 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.69) | |||
| Treynor Ratio | (2.14) | |||
| Maximum Drawdown | 17.74 | |||
| Value At Risk | (4.00) | |||
| Potential Upside | 5.6 | |||
| Skewness | 1.19 | |||
| Kurtosis | 2.81 |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (2.13) | |||
| Mean Deviation | 2.25 | |||
| Coefficient Of Variation | (1,871) | |||
| Standard Deviation | 3.1 | |||
| Variance | 9.61 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.69) | |||
| Treynor Ratio | (2.14) | |||
| Maximum Drawdown | 17.74 | |||
| Value At Risk | (4.00) | |||
| Potential Upside | 5.6 | |||
| Skewness | 1.19 | |||
| Kurtosis | 2.81 |
Consider Sellas Life's intraday indicators
Sellas Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sellas Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 82242.53 | |||
| Daily Balance Of Power | (0.36) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 1.18 | |||
| Day Typical Price | 1.16 | |||
| Price Action Indicator | (0.07) | |||
| Period Momentum Indicator | (0.04) | |||
| Relative Strength Index | 57.07 |
Sellas Stock media impact
Far too much social signal, news, headlines, and media speculation about Sellas Life that are available to investors today. That information is available publicly through Sellas media outlets and privately through word of mouth or via Sellas internal channels. However, regardless of the origin, that massive amount of Sellas data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Sellas Life news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Sellas Life relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Sellas Life's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Sellas Life alpha.
Sellas Life Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Sellas Life can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Sellas Life Corporate Management
| Barbara Esq | General VP | Profile | |
| Stacy Yeung | Associate VP | Profile | |
| Jrg Breitkopf | Head Operations | Profile | |
| ScD MD | President, Founder | Profile | |
| Barbara Wood | Gen VP | Profile | |
| Andrew Elnatan | Chemistry, Affairs | Profile | |
| Robert Francomano | Senior Officer | Profile |
Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.